缺氧对GLP-1分泌的影响 - - 一项使用肠内分泌STC-1细胞作为模型的体外研究
Ravikant Sharma1, Ghulam Shere Raza1, Nalini Sodum1
1Research Unit of Biomedicine and Internal Medicine, Biocenter of Oulu, Medical Research Center, University of Oulu, Aapistie 5, 90220, Oulu, Finland.
Pflugers Archiv : European journal of physiology
|July 29, 2024
概括
缺氧通过降低GPR120和GPR40受体在肠内分泌细胞中的表达来降低营养刺激的葡萄糖样 (GLP) -1分泌. 基底GLP-1分泌仍不受低氧条件的影响.
科学领域:
- 内分泌学 在内分泌学.
- 胃肠病学 胃肠病学
- 细胞生物学 细胞生物学
背景情况:
- 葡萄糖类 (GLP) -1 在摄入后由肠内分泌L细胞分泌.
- L细胞通过G蛋白结合受体 (GPRs) 感知营养.
- 肠道L细胞经历过缺氧,原因是光线附近的氧气张力较低.
研究的目的:
- 为了研究缺氧对营养刺激GLP-1分泌的影响.
- 为了检查缺氧对STC-1细胞GPR表达的影响.
- 为了确定缺氧是否影响α-烯酸 (αLA) 诱导的GLP-1释放.
主要方法:
- STC-1细胞被暴露在低氧 (1% O2) 中12小时.
- 细胞被用α-烯酸 (αLA) 处理以刺激GLP-1分泌.
- 测量了GLP-1分泌和GPR120/GPR40表达水平.
主要成果:
- 低氧并没有改变基底GLP-1分泌.
- 营养素 (αLA) 刺激的GLP-1分泌物在缺氧下显著减少 (45%的减少).
- 与normoxia相比,低氧降低了GPR120 (50%) 和GPR40 (60%) 的表达.
结论:
- 缺氧会影响营养刺激的GLP-1从肠内分泌细胞分泌.
- 缺氧下GLP-1分泌量的减少归因于GPR120和GPR40表达的减少.
- 肠道环境的变化和炎症可能会导致L细胞缺氧.
相关概念视频
Glucose Homeostasis: Pancreatic Islets and Insulin Secretion
1.2K
The pancreatic islets comprising only 1%-2% of the volume are highly vascularized and innervated mini-organs. They contain five endocrine cell types, including β cells that secrete insulin, which is synthesized as a single polypeptide chain, preproinsulin, processed to proinsulin, and finally to insulin and C-peptide. This process is complex and regulated, involving the Golgi complex, the endoplasmic reticulum, and the secretory granules of the β cell.
Insulin and C-peptide are...
Insulin and C-peptide are...
1.2K
Glucagon-like Receptor Agonists
312
Incretins include glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP), which stimulate insulin secretion post-meals. In type 2 diabetes, GIP's efficacy is reduced, making GLP-1 a viable drug target. GIP originates from preproGIP.
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
312


